COVIDIAGNOSTIX - Health Technology Assessment in Covid serological diagnostics - Data OPBG
Description
COVIDIAGNOSTIX - Health Technology Assessment in Covid serological diagnostics.
SARS-COV-2 serologcal results, obtained in serial evaluations at 0,1,3,6 months from the first dose of anti-Sars-CoV-2 vaccine, in the healthcare workers of the Bambino Gesù Children' Hospital. The antibody dosage was performed with the Roche (anti-N and anti-S) and DiaSorin (anti-S Trimeric) assays.
COVID-2020-12371619 funded by the Italian Ministry of Health - Codice CUP C49C20000080001
Files
Files
(61.2 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:ce8fd9fb832b6866a8a285e5dda45be7
|
61.2 kB | Download |